Pfizer Inc Gains FDA Approval for New Colorectal Cancer Treatment
| KDHAX Fund | USD 54.36 0.24 0.44% |
Slightly above 61% of Deutsche Croci's investor base is looking to short. The analysis of overall sentiment of trading Deutsche Croci Equity mutual fund suggests that many investors are alarmed at this time. Deutsche Croci's investing sentiment can be driven by a variety of factors including economic data, Deutsche Croci's earnings reports, geopolitical events, and overall market trends.
Deutsche |
Pfizer Inc announced on December 20, 2024, that the U.S. Food and Drug Administration has approved the use of BRAFTOVI in combinatio
Read at gurufocus.com
 |
Deutsche Croci Fundamental Analysis
We analyze Deutsche Croci's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deutsche Croci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deutsche Croci based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
Deutsche Croci is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
Deutsche Croci Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deutsche Croci mutual fund to make a market-neutral strategy. Peer analysis of Deutsche Croci could also be used in its relative valuation, which is a method of valuing Deutsche Croci by comparing valuation metrics with similar companies.
Peers
Deutsche Croci Related Equities
| KTCSX | Deutsche Science | 0.98 | ||||
| KTCCX | Deutsche Science | 0.93 | ||||
| KTRAX | Deutsche Global | 0.23 | ||||
| KTRCX | Deutsche Global | 0.23 | ||||
| SRMAX | Deutsche Short | 0.10 | ||||
| SRMCX | Deutsche Short | 0.10 | ||||
| SRMSX | Deutsche Short | 0.00 | ||||
| GCGGX | Deutsche Gnma | 0.09 | ||||
| KTCIX | Deutsche Science | 1.30 | ||||
| KTCAX | Deutsche Science | 1.31 |
Other Information on Investing in Deutsche Mutual Fund
Deutsche Croci financial ratios help investors to determine whether Deutsche Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deutsche with respect to the benefits of owning Deutsche Croci security.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |